News

July 25, 2007 - Teleflex Incorporated, a diversified company expanding medical technology business, and Arrow ...

Home July 24, 2007
Home
News

July 25, 2007 - St. Jude Medical, Inc. announced the first patient implant in its clinical trial of Trifecta, a new ...

Home July 24, 2007
Home
News

July 25, 2007 - Researchers have confirmed that six new genetic variants increase the likelihood of developing coronary ...

Home July 24, 2007
Home
News

July 25, 2007 โ€“ Multidetector computed tomography (MDCT) angiography is highly accurate in depicting intracranial ...

Home July 24, 2007
Home
News

July 24, 2007 โ€“ Biotonik announced that it has enrolled the first patient and largest trial, REPLACE Registry, which ...

Home July 23, 2007
Home
News

July 24, 2007 - A new U.S. study published in the early online edition of Circulation, the journal of the American Heart ...

Home July 23, 2007
Home
News

July 22, 2007 โ€“ ev3 Inc. and FoxHollow Technologies, Inc. announced a definitive agreement by which ev3 and FoxHollow ...

Home July 22, 2007
Home
News

July 23, 2007 - Teleflex Inc., a global supplier of disposable medical products used in critical care, specialty medical, and surgical applications and Arrow International Inc. announced today that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.

Home July 22, 2007
Home
News

Source: Wall Street Journal Online July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...

Home July 19, 2007
Home
News

July 19, 2007 โ€“ Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...

Home July 19, 2007
Home
News

July 20, 2007 โ€“ Despite forecasts by analysts at Thomson Financial that Boston Scientific Corp. would earn $150 million ...

Home July 19, 2007
Home
News

July 20, 2007 โ€“ Oraganogenesis Inc. announced that it has received regulatory approval in Canada and Europe for BioSTAR, a device that incorporates a bioresorbable collagen scaffold used to treat patent foramen ovale (PFO), a hole in the heart that is usually asymptomatic.

Home July 19, 2007
Home
News

July 19, 2007 โ€“ AtCor Medical Holdings Ltd., the developer and marketer of the SphygmoCor system, which noninvasively ...

Home July 18, 2007
Home
News

July 18, 2007 - An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated ...

Home July 17, 2007
Home
News

July 18, 2008 - Cardium Therapeutics announced that the FDA has given it clearance for fast track designation to its ...

Home July 17, 2007
Home
Subscribe Now